Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
European Journal of Gastroenterology & Hepatology
|
October 23, 2010
High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patients
Patrick Marcellin, Jean-François Cadranel, Thierry Fontanges, et al.
Gastroenterology
|
October 3, 2002
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C
John G McHutchison, Michael Manns, Keyur Patel, et al.
The Journal of General Virology
|
October 20, 2012
Identification of novel recombinants of hepatitis B virus genotypes F and G in human immunodeficiency virus-positive patients from Argentina and Brazil
Natalia M Araujo, Oscar C Araujo, Edinete M Silva, et al.
Journal of Hepatology
|
November 9, 2010
Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma
Sarah Beseme Nambotin, Lydie Lefrancois, Xavier Sainsily, et al.
Cancer Letters
|
August 2, 2006
Efficient hepatitis C antigen immunohistological staining in sections of normal, cirrhotic and tumoral liver using a new monoclonal antibody directed against serum-derived HCV E2 glycoproteins
Oivier Galy, Marie-Anne Petit, Soumaya Benjelloun, et al.
Journal of Medical Virology
|
June 2, 2004
The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment
Pierre Pradat, Marianne Maynard, Maria Buti, et al.
Vaccine
|
November 23, 2007
Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine
Pierre Vandepapelière, George K K Lau, Geert Leroux-Roels, et al.
The American Journal of Gastroenterology
|
September 1, 2005
Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection
Thierry Poynard, Fabien Zoulim, Vlad Ratziu, et al.
The Journal of Infection
|
June 7, 2011
Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers
Bouchra Kitab, Abdellah Essaid El Feydi, Rajaa Afifi, et al.
Gastroenterology
|
March 4, 2003
Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study
Didier Samuel, Thierry Bizollon, Cyrille Feray, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
European Journal of Gastroenterology & Hepatology
|
October 23, 2010
High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patients
Patrick Marcellin, Jean-François Cadranel, Thierry Fontanges, et al.
Gastroenterology
|
October 3, 2002
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C
John G McHutchison, Michael Manns, Keyur Patel, et al.
The Journal of General Virology
|
October 20, 2012
Identification of novel recombinants of hepatitis B virus genotypes F and G in human immunodeficiency virus-positive patients from Argentina and Brazil
Natalia M Araujo, Oscar C Araujo, Edinete M Silva, et al.
Journal of Hepatology
|
November 9, 2010
Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma
Sarah Beseme Nambotin, Lydie Lefrancois, Xavier Sainsily, et al.
Cancer Letters
|
August 2, 2006
Efficient hepatitis C antigen immunohistological staining in sections of normal, cirrhotic and tumoral liver using a new monoclonal antibody directed against serum-derived HCV E2 glycoproteins
Oivier Galy, Marie-Anne Petit, Soumaya Benjelloun, et al.
Journal of Medical Virology
|
June 2, 2004
The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment
Pierre Pradat, Marianne Maynard, Maria Buti, et al.
Vaccine
|
November 23, 2007
Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine
Pierre Vandepapelière, George K K Lau, Geert Leroux-Roels, et al.
The American Journal of Gastroenterology
|
September 1, 2005
Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection
Thierry Poynard, Fabien Zoulim, Vlad Ratziu, et al.
The Journal of Infection
|
June 7, 2011
Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers
Bouchra Kitab, Abdellah Essaid El Feydi, Rajaa Afifi, et al.
Gastroenterology
|
March 4, 2003
Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study
Didier Samuel, Thierry Bizollon, Cyrille Feray, et al.
Page
of 7